Skip to content
HowShorted

Co-Diagnostics, Inc. short interest in 2024

In 2024, Co-Diagnostics, Inc.'s disclosed short interest ran from 1.86% of shares outstanding on 12 Jan 2024 to 1.01% on 31 Dec 2024, a change of -0.85 percentage points. The year's high was 1.86% on 12 Jan 2024 and its low 0.64% on 30 Sep 2024, averaging 1.09% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 10.45 days on 15 Feb 2024. Full history: Co-Diagnostics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Co-Diagnostics, Inc. in 2024

2024 in figures

Start of year
1.86% (12 Jan 2024)
End of year
1.01% (31 Dec 2024)
Change
-0.85 pp
High
1.86% (12 Jan 2024)
Low
0.64% (30 Sep 2024)
Average
1.09%
Highest days to cover
10.45 (15 Feb 2024)
SEC filings marked
8

Every report in 2024

Co-Diagnostics, Inc. short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 20241.86%5.27
31 Jan 20241.18%5.52
15 Feb 20241.56%10.45
29 Feb 20241.12%5.83
15 Mar 20241.22%6.5010-K filed, results (8-K)
28 Mar 20241.59%8.14
15 Apr 20241.45%6.67
30 Apr 20241.45%8.41
15 May 20241.01%6.0810-Q filed, results (8-K)
31 May 20241.16%6.09
14 Jun 20241.13%1.00
28 Jun 20241.42%2.79
15 Jul 20241.13%5.16
31 Jul 20240.99%4.20
15 Aug 20240.94%3.1410-Q filed, results (8-K)
30 Aug 20241.02%1.00
13 Sep 20240.71%1.07
30 Sep 20240.64%2.47
15 Oct 20240.71%2.50
31 Oct 20240.65%3.04
15 Nov 20240.72%2.4710-Q filed, results (8-K)
29 Nov 20240.71%1.16
13 Dec 20240.73%1.91
31 Dec 20241.01%1.40

See also: Co-Diagnostics, Inc.'s full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.